Sort by

Send to

Choose Destination

Search results

Items: 2


Dendritic cells treated with lipopolysaccharide up-regulate serine protease inhibitor 6 and remain sensitive to killing by cytotoxic T lymphocytes in vivo.

Andrew KA, Simkins HM, Witzel S, Perret R, Hudson J, Hermans IF, Ritchie DS, Yang J, Ronchese F.

J Immunol. 2008 Dec 15;181(12):8356-62.


Activation and route of administration both determine the ability of bone marrow-derived dendritic cells to accumulate in secondary lymphoid organs and prime CD8+ T cells against tumors.

Huck SP, Tang SC, Andrew KA, Yang J, Harper JL, Ronchese F.

Cancer Immunol Immunother. 2008 Jan;57(1):63-71. Epub 2007 Jul 3.


Supplemental Content

Loading ...
Support Center